Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Interest Expenses (2019 - 2025)

Pulmonx has reported Interest Expenses over the past 7 years, most recently at $805000.0 for Q3 2025.

  • Quarterly Interest Expenses fell 9.65% to $805000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 31.99% year-over-year, with the annual reading at $3.5 million for FY2024, 8.51% up from the prior year.
  • Interest Expenses was $805000.0 for Q3 2025 at Pulmonx, up from $799000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $905000.0 in Q4 2023 and troughed at $198000.0 in Q1 2022.
  • The 5-year median for Interest Expenses is $781000.0 (2025), against an average of $580000.0.
  • Year-over-year, Interest Expenses crashed 81.23% in 2021 and then surged 287.44% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $199000.0 in 2021, then soared by 80.4% to $359000.0 in 2022, then surged by 152.09% to $905000.0 in 2023, then dropped by 6.96% to $842000.0 in 2024, then dropped by 4.39% to $805000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Interest Expenses are $805000.0 (Q3 2025), $799000.0 (Q2 2025), and $781000.0 (Q1 2025).